BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis

  April 7, 2025

   · 

  6 min read
• Press Releases

  Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

  April 7, 2025

   · 

  2 min read
• Press Releases

  Endo to Report First Quarter 2025 Financial Results on May 7, 2025

  April 7, 2025

   · 

  1 min read
• Press Releases

  Vertex to Announce First Quarter 2025 Financial Results on May 5th

  April 7, 2025

   · 

  1 min read
• Press Releases

  Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference

  April 7, 2025

   · 

  1 min read
• Press Releases

  Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

  April 7, 2025

   · 

  7 min read
• Press Releases

  Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

  April 7, 2025

   · 

  1 min read
• Press Releases

  Oasis Files Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors

  April 7, 2025

   · 

  4 min read
• Press Releases

  LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer

  April 7, 2025

   · 

  3 min read
• European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility

  April 7, 2025

   · 

  14 min read